Carroll-Baccari Inc – FDA 483, Aug 5, 2025
The FDA inspection of Mavidon Medical Products in Flat Rock, NC, revealed widespread deficiencies across its quality management system, indicating a lack of adequate controls for medical device manufacturing. Significant issues include ineffective corrective and preventive actions, inadequate control of non-conforming products, and insufficient process controls. The firm also failed to establish proper procedures for complaint handling, equipment calibration, supplier management, product identification, software validation, MDR reporting, personnel training, and document control, posing risks to product quality and patient safety.
- Office
- Atlanta District Office
- Person
ID · 6b0aadaa-a56b-4046-91be-9e0a49adf937
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.